Contents
Academy · Checklists · Meta-Analysis Planning
There Is No Official “Meta-Analysis Planning Checklist.” PRISMA-P, the Cochrane Handbook and PROSPERO Are the Real Instruments That Govern This Stage
No single, formally named, citable checklist for planning a meta-analysis exists alongside PRISMA, STROBE or CONSORT. What follows is Pubrica’s own practical planning guide, built on PRISMA-P 2015, the Cochrane Handbook’s planning chapters, and PROSPERO’s registration requirements — named as such, not presented as a citation to one official instrument.
Before any literature search or data extraction begins, a review team has to lock down a question, pre-specify eligibility criteria, decide a search strategy, decide how risk of bias will be assessed, decide the synthesis approach, and register the protocol — all to protect against post-hoc, results-driven decisions, a well-documented source of bias in meta-analyses. PRISMA-P 2015 (Moher D, Shamseer L, Clarke M, et al., Systematic Reviews, 2015) is the real, EQUATOR-listed checklist for writing up that plan as a protocol.
What it is
No developing body or publication exists for a checklist under this specific name. The real instruments are: Moher D, Shamseer L, Clarke M, et al. “Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.” Systematic Reviews, 2015;4:1; the Cochrane Handbook for Systematic Reviews of Interventions, early chapters on starting a review and writing a protocol; and PROSPERO’s structured registration form.
To pre-specify every major decision — eligibility, search strategy, risk-of-bias tool, synthesis model — before the literature search begins, so later choices cannot be shaped by which results happen to turn up. PRISMA-P exists to standardise how that plan is written up; PROSPERO exists to make it a time-stamped, public record.
The planning stage preceding any systematic review intended to include a meta-analysis — the period between deciding to do a review and actually starting the search or data extraction. Distinct from PRISMA 2020, which applies only once the review is finished and being written up.
Is this the right tool?
Use it when
Researchers and medical writers at the protocol-development stage, before any searching or screening begins; teams preparing a PROSPERO or OSF registration; grant or ethics reviewers assessing a proposed review’s rigour before it starts.
Not the right tool when
PRISMA-P should never be used to report a completed review — that is PRISMA 2020’s job, and using PRISMA-P language in a final published review is a real, common error. PROSPERO registration is not itself a planning tool — it requires a near-complete protocol to already exist before registration, so treating registration as the first planning step rather than a late one is a misuse.
The real planning steps
Pubrica’s own compiled practical guide, grounded in PRISMA-P, the Cochrane Handbook, and PROSPERO — not a citation to one official instrument.
Before the protocol is written
| Item | What it requires |
|---|---|
| 1. Define the review question | Using PICO or an equivalent framework; confirm a meta-analysis is actually a sensible goal — that enough comparable studies are likely to exist. |
| 2. Check for existing or ongoing reviews | Search PROSPERO and the literature to avoid unplanned duplication. |
| 3. Assemble the team and roles | Including at least one person with meta-analysis or biostatistics expertise, per Cochrane Handbook guidance. |
| 4. Pre-specify eligibility criteria | Study designs, populations, interventions or exposures, comparators, outcomes, publication types, date and language limits — decided before searching. |
Writing the protocol
| Item | What it requires |
|---|---|
| 5. Draft the search strategy | Databases, search terms, grey-literature sources, and a plan for handling duplicate records, per PRISMA-P’s search items. |
| 6. Pre-specify screening and extraction methods | Number of independent reviewers, disagreement-resolution process, and data-extraction form fields. |
| 7. Pre-specify the risk-of-bias tool | E.g., Cochrane RoB 2, ROBINS-I, Newcastle-Ottawa — decided in advance, not chosen post hoc. |
| 8. Pre-specify the synthesis plan | Effect measure, model choice (fixed vs. random effects), heterogeneity assessment, subgroup/sensitivity analyses, and the logic for falling back to narrative synthesis if needed. |
| 9. Register the protocol | PROSPERO, or an equivalent registry/journal, which itself performs a final completeness check on the above. |
Applying it, with the evidence
Planning decisions made before data are seen — the synthesis method, how heterogeneity and missing data will be handled, pre-specified subgroup and sensitivity analyses — are what protect a meta-analysis from data-driven, post-hoc choices that inflate false positives. A large audit of PROSPERO records found the meta-analysis-specific planning items were among the weakest reported of all PRISMA-P elements, showing planning is frequently done poorly even when researchers do register in advance.
Systematic reviews and meta-analyses across all health and social-science fields that use PROSPERO or OSF for prospective registration; most rigorously enforced in Cochrane reviews and in journals such as BMJ and Systematic Reviews that require a registered protocol before accepting the final review.
In order
Where it goes right
With it — no verifiable example found
Our research for this page did not turn up a named, checkable published paper that explicitly credits this checklist for a well-reported study. Rather than invent one, we are saying so. If you know of one, the EQUATOR Network page for this guideline is the place such examples tend to get collected.
Common mistakes
- Choosing the statistical model or subgroup analyses only after seeing results is a serious, well-documented bias. All of this belongs in the protocol, decided before data are seen.
- Vague PROSPERO eligibility criteria (“adult patients” with no age range or condition specified) undercut the registration’s purpose. PROSPERO’s own guidance expects precision at registration.
- Confusing PRISMA-P (protocol stage) with PRISMA 2020 (final report stage) is common and worth flagging explicitly. Submitting the wrong checklist to a journal is an avoidable, recurring error.
Where it falls short
Where planning falls short — Booth et al. 2020, 433 PROSPERO records
Randomly sampling 433 non-Cochrane PROSPERO records (2018) against 19 PRISMA-P items, only about 25% of items and 53% of elements were adequately reported overall. Meta-analysis planning was the weakest domain specifically: the statistical synthesis method was not reported in 64% of records; sensitivity analyses were not planned in 65%; subgroup-analysis methods were not reported in 65%; and handling of missing data — the single weakest element — was reported in only 3%. Protocols that did plan a meta-analysis scored lower overall (23% of items) than those that did not (29%).
Booth A, Mitchell AS, Mott A, et al. “An assessment of the extent to which the contents of PROSPERO records meet the systematic review protocol reporting items in PRISMA-P.” F1000Research, 2020;9:773. doi.org/10.12688/f1000research.25181.2.
Common questions
No. No search of PROSPERO’s documentation, the Cochrane Handbook, or the methodology literature turns up an official checklist by this name. The real, citable instrument is PRISMA-P 2015, supported by the Cochrane Handbook’s planning chapters and PROSPERO’s registration requirements.
Cite PRISMA-P 2015 (Moher et al., Systematic Reviews, 2015) for protocol reporting, and the current Cochrane Handbook for the underlying planning process; note PROSPERO’s guidance for the registration step itself.
Not really — PROSPERO explicitly requires a full protocol to be ready before registering. Registration is the final, time-stamped checkpoint at the end of planning, not the planning process itself.
References and sources
- Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews, 2015;4:1. read 8 October 2026. doi.org/10.1186/2046-4053-4-1
- PROSPERO. Guidance for registering human studies. read 8 October 2026. crd.york.ac.uk
Each source carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 8). There Is No Official “Meta-Analysis Planning Checklist.” PRISMA-P, the Cochrane Handbook and PROSPERO Are the Real Instruments That Govern This Stage. Pubrica. https://pubrica.com/insights/checklist/preliminary-planning-meta-analysis-checklist/
Pubrica Academy. “There Is No Official “Meta-Analysis Planning Checklist.” PRISMA-P, the Cochrane Handbook and PROSPERO Are the Real Instruments that Govern This Stage.” Pubrica, 8 Oct. 2026, pubrica.com/insights/checklist/preliminary-planning-meta-analysis-checklist/.
Pubrica Academy (2026) There Is No Official “Meta-Analysis Planning Checklist.” PRISMA-P, the Cochrane Handbook and PROSPERO Are the Real Instruments That Govern This Stage. Pubrica. Available at: https://pubrica.com/insights/checklist/preliminary-planning-meta-analysis-checklist/ (Accessed: 15 October 2026).
Pubrica Academy. “There Is No Official “Meta-Analysis Planning Checklist.” PRISMA-P, the Cochrane Handbook and PROSPERO Are the Real Instruments that Govern This Stage.” Pubrica. October 8, 2026. https://pubrica.com/insights/checklist/preliminary-planning-meta-analysis-checklist/
Pubrica Academy, ‘There Is No Official “Meta-Analysis Planning Checklist.” PRISMA-P, the Cochrane Handbook and PROSPERO Are the Real Instruments That Govern This Stage’ (Pubrica, 8 October 2026) <https://pubrica.com/insights/checklist/preliminary-planning-meta-analysis-checklist/> accessed 15 October 2026.
Pubrica Academy. There Is No Official “Meta-Analysis Planning Checklist.” PRISMA-P, the Cochrane Handbook and PROSPERO Are the Real Instruments That Govern This Stage. [Internet]. Pubrica; 2026 Oct 8 [cited 2026 Oct 15]. Available from: https://pubrica.com/insights/checklist/preliminary-planning-meta-analysis-checklist/
Pubrica Academy, “There Is No Official “Meta-Analysis Planning Checklist.” PRISMA-P, the Cochrane Handbook and PROSPERO Are the Real Instruments That Govern This Stage,” Pubrica, Oct. 8, 2026. [Online]. Available: https://pubrica.com/insights/checklist/preliminary-planning-meta-analysis-checklist/
@misc{preliminary_planning_meta_analysis_che_2026,
author = {{Pubrica Academy}},
title = {There Is No Official “Meta-Analysis Planning Checklist.” PRISMA-P, the Cochrane Handbook and PROSPERO Are the Real Instruments That Govern This Stage},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/insights/checklist/preliminary-planning-meta-analysis-checklist/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Pubrica AcademyWritten and maintained by the subject matter experts of Pubrica who do this work. Articles are revised when the standard underneath them moves, and each one carries the date it was last checked.
How Pubrica helps
Pubrica’s evidence-synthesis team resolves the synthesis model, risk-of-bias tool and subgroup plan before the search begins, and registers the protocol on PROSPERO before data extraction starts.